{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:41Z","timestamp":1791910601330,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,18]]},"DOI":"10.7759\/cureus.97174","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T22:04:21Z","timestamp":1763503461000},"source":"Crossref","is-referenced-by-count":1,"title":["Real-World Effectiveness and Safety of Daridorexant in Japanese Patients With Insomnia: A Multicenter Observational Study Evaluating Four-Week Changes in Athens Insomnia Scale Among 54 Participants"],"prefix":"10.7759","author":[{"given":"Soichi","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.05.013","article-title":"Nationwide epidemiological study of insomnia in Japan","volume":"25","author":"Itani O","year":"2016","unstructured":"Itani O, Kaneita Y, Munezawa T, et al.. Nationwide epidemiological study of insomnia in Japan. Sleep Med. 2016, 25:130-8. 10.1016\/j.sleep.2016.05.013","journal-title":"Sleep Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2024.103936","article-title":"Insomnia, anxiety and related disorders: a systematic review on clinical and therapeutic perspective with potential mechanisms underlying their complex link","volume":"3","author":"Palagini L","year":"2024","unstructured":"Palagini L, Miniati M, Caruso V, et al.. Insomnia, anxiety and related disorders: a systematic review on clinical and therapeutic perspective with potential mechanisms underlying their complex link. Neurosci Appl. 2024, 3:103936. 10.1016\/j.nsa.2024.103936","journal-title":"Neurosci Appl"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.16.1775","article-title":"Insomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 national health interview survey data","volume":"166","author":"Pearson NJ","year":"2006","unstructured":"Pearson NJ, Johnson LL, Nahin RL. Insomnia, trouble sleeping, and complementary and alternative medicine: analysis of the 2002 national health interview survey data. Arch Intern Med. 2006, 166:1775-82. 10.1001\/archinte.166.16.1775","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16061083","article-title":"Sleep disturbance in adjustment disorder and depressive episode","volume":"16","author":"Doherty AM","year":"2019","unstructured":"Doherty AM, Lorenz L, Jabbar F, O'Leary E, Casey P. Sleep disturbance in adjustment disorder and depressive episode. Int J Environ Res Public Health. 2019, 16:10.3390\/ijerph16061083","journal-title":"Int J Environ Res Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.11.021","article-title":"Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies","volume":"215","author":"Wu TT","year":"2023","unstructured":"Wu TT, Zou YL, Xu KD, Jiang XR, Zhou MM, Zhang SB, Song CH. Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies. Public Health. 2023, 215:66-74. 10.1016\/j.puhe.2022.11.021","journal-title":"Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52014","article-title":"Insomnia and workplace productivity loss among young working adults: a prospective observational study of clinical sleep disorders in a community cohort","volume":"219","author":"Reynolds AC","year":"2023","unstructured":"Reynolds AC, Coenen P, Lechat B, et al.. Insomnia and workplace productivity loss among young working adults: a prospective observational study of clinical sleep disorders in a community cohort. Med J Aust. 2023, 219:107-12. 10.5694\/mja2.52014","journal-title":"Med J Aust"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1471457","article-title":"Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study","volume":"15","author":"Komatsu M","year":"2024","unstructured":"Komatsu M, Takeshima M, Yoshizawa K, et al.. Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study. Front Psychiatry. 2024, 15:1471457. 10.3389\/fpsyt.2024.1471457","journal-title":"Front Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann D","year":"2017","unstructured":"Riemann D, Baglioni C, Bassetti C, et al.. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017, 26:675-700. 10.1111\/jsr.12594","journal-title":"J Sleep Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann D","year":"2023","unstructured":"Riemann D, Espie CA, Altena E, et al.. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023, 32:e14035. 10.1111\/jsr.14035","journal-title":"J Sleep Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1168100","article-title":"Treatment strategy for insomnia disorder: Japanese expert consensus","volume":"14","author":"Takaesu Y","year":"2023","unstructured":"Takaesu Y, Sakurai H, Aoki Y, et al.. Treatment strategy for insomnia disorder: Japanese expert consensus. Front Psychiatry. 2023, 14:1168100. 10.3389\/fpsyt.2023.1168100","journal-title":"Front Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pcn5.113","article-title":"Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists","volume":"2","author":"Usui K","year":"2023","unstructured":"Usui K, Kikuchi D, Otsuka N, et al.. Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists. PCN Rep. 2023, 2:e113. 10.1002\/pcn5.113","journal-title":"PCN Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14302","article-title":"Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: results from phase 1 and 2 studies","volume":"34","author":"Uchiyama M","year":"2025","unstructured":"Uchiyama M, Mishima K, Yagi T, et al.. Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: results from phase 1 and 2 studies. J Sleep Res. 2025, 34:e14302. 10.1111\/jsr.14302","journal-title":"J Sleep Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.07.037","article-title":"Daridorexant in Japanese patients with insomnia disorder: a phase 3, randomized, double-blind, placebo-controlled study","volume":"122","author":"Uchimura N","year":"2024","unstructured":"Uchimura N, Taniguchi M, Ariyoshi Y, Oka Y, Togo O, Uchiyama M. Daridorexant in Japanese patients with insomnia disorder: a phase 3, randomized, double-blind, placebo-controlled study. Sleep Med. 2024, 122:27-34. 10.1016\/j.sleep.2024.07.037","journal-title":"Sleep Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo F","year":"2022","unstructured":"De Crescenzo F, D'Al\u00f2 GL, Ostinelli EG, et al.. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022, 400:170-84. 10.1016\/S0140-6736(22)00878-9","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12073","article-title":"Development and validation of the Japanese version of the Athens Insomnia Scale","volume":"67","author":"Okajima I","year":"2013","unstructured":"Okajima I, Nakajima S, Kobayashi M, Inoue Y. Development and validation of the Japanese version of the Athens Insomnia Scale. Psychiatry Clin Neurosci. 2013, 67:420-5. 10.1111\/pcn.12073","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3999(02)00604-9","article-title":"The diagnostic validity of the Athens Insomnia Scale","volume":"55","author":"Soldatos CR","year":"2003","unstructured":"Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale.  J Psychosom Res. 2003, 55:263-7. 10.1016\/s0022-3999(02)00604-9","journal-title":"J Psychosom Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3999(00)00095-7","article-title":"Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria","volume":"48","author":"Soldatos CR","year":"2000","unstructured":"Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000, 48:555-60. 10.1016\/s0022-3999(00)00095-7","journal-title":"J Psychosom Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17238789","article-title":"Evaluation of severity levels of the Athens Insomnia Scale based on the criterion of Insomnia Severity Index","volume":"17","author":"Okajima I","year":"2020","unstructured":"Okajima I, Miyamoto T, Ubara A, et al.. Evaluation of severity levels of the Athens Insomnia Scale based on the criterion of Insomnia Severity Index. Int J Environ Res Public Health. 2020, 17:10.3390\/ijerph17238789","journal-title":"Int J Environ Res Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2016.06.010","article-title":"A meta-analysis of diagnostic accuracy of three screening tools for insomnia","volume":"87","author":"Chiu HY","year":"2016","unstructured":"Chiu HY, Chang LY, Hsieh YJ, Tsai PS. A meta-analysis of diagnostic accuracy of three screening tools for insomnia. J Psychosom Res. 2016, 87:85-92. 10.1016\/j.jpsychores.2016.06.010","journal-title":"J Psychosom Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsae098","article-title":"Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies","volume":"47","author":"Di Marco T","year":"2024","unstructured":"Di Marco T, Djonlagic I, Dauvilliers Y, et al.. Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies. Sleep. 2024, 47:10.1093\/sleep\/zsae098","journal-title":"Sleep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00436-1","article-title":"Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials","volume":"21","author":"Mignot E","year":"2022","unstructured":"Mignot E, Mayleben D, Fietze I, et al.. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Lancet Neurol. 2022, 21:125-39. 10.1016\/S1474-4422(21)00436-1","journal-title":"Lancet Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093240","article-title":"Use of daridorexant among patients with chronic insomnia: a retrospective observational analysis","volume":"12","author":"Williams SG","year":"2023","unstructured":"Williams SG, Rodriguez-Cu\u00e9 D. Use of daridorexant among patients with chronic insomnia: a retrospective observational analysis. J Clin Med. 2023, 12:10.3390\/jcm12093240","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.24m03810","article-title":"Effect of lemborexant on daytime functioning in adults with insomnia: patient-reported outcomes from a phase 3 clinical trial","volume":"27","author":"Chepke C","year":"2025","unstructured":"Chepke C, Cote KA, Pinner K, Yardley J, Lundwall C, Moline M. Effect of lemborexant on daytime functioning in adults with insomnia: patient-reported outcomes from a phase 3 clinical trial. Prim Care Companion CNS Disord. 2025, 27:10.4088\/PCC.24m03810","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07326-w","article-title":"Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study","volume":"45","author":"Fernandes M","year":"2024","unstructured":"Fernandes M, Placidi F, Mercuri NB, Liguori C. Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study. Neurol Sci. 2024, 45:3443-8. 10.1007\/s10072-024-07326-w","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnad126","article-title":"Improvement of sleep and pain with lemborexant administration in patients with chronic pain: a retrospective observational study","volume":"25","author":"Ueno K","year":"2024","unstructured":"Ueno K, Sato H, Nomura Y, Obata N, Mizobuchi S. Improvement of sleep and pain with lemborexant administration in patients with chronic pain: a retrospective observational study. Pain Med. 2024, 25:139-43. 10.1093\/pm\/pnad126","journal-title":"Pain Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14196","article-title":"Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: results of a naturalistic study with 3\u2009months follow-up","volume":"33","author":"Palagini L","year":"2024","unstructured":"Palagini L, Alfi G, Gurrieri R, et al.. Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: results of a naturalistic study with 3\u2009months follow-up. J Sleep Res. 2024, 33:e14196. 10.1111\/jsr.14196","journal-title":"J Sleep Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-024-02811-2","article-title":"Efficacy and safety of transitioning to lemborexant from Z-drug, suvorexant, and ramelteon in Japanese insomnia patients: an open-label, multicenter study","volume":"41","author":"Ozone M","year":"2024","unstructured":"Ozone M, Hirota S, Ariyoshi Y, et al.. Efficacy and safety of transitioning to lemborexant from Z-drug, suvorexant, and ramelteon in Japanese insomnia patients: an open-label, multicenter study. Adv Ther. 2024, 41:1728-45. 10.1007\/s12325-024-02811-2","journal-title":"Adv Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi T","year":"2024","unstructured":"Kishi T, Koebis M, Sugawara M, Kawatsu Y, Taninaga T, Iwata N. Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review. Transl Psychiatry. 2024, 14:374. 10.1038\/s41398-024-03087-4","journal-title":"Transl Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.29399\/npa.28383","article-title":"Orexin receptor antagonists as adjunct drugs for the treatment of depression: a mini meta-analysis","volume":"61","author":"U\u011furlu M","year":"2024","unstructured":"U\u011furlu M. Orexin receptor antagonists as adjunct drugs for the treatment of depression: a mini meta-analysis. Noro Psikiyatr Ars. 2024, 61:77-84. 10.29399\/npa.28383","journal-title":"Noro Psikiyatr Ars"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.07.036","article-title":"Long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder","volume":"122","author":"Uchimura N","year":"2024","unstructured":"Uchimura N, Ozone M, Suzuki M, Taniguchi M, Kuriyama K, Togo O, Uchiyama M. Long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder. Sleep Med. 2024, 122:64-70. 10.1016\/j.sleep.2024.07.036","journal-title":"Sleep Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382798-real-world-effectiveness-and-safety-of-daridorexant-in-japanese-patients-with-insomnia-a-multicenter-observational-study-evaluating-four-week-changes-in-athens-insomnia-scale-among-54-participants","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T22:04:22Z","timestamp":1763503462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382798-real-world-effectiveness-and-safety-of-daridorexant-in-japanese-patients-with-insomnia-a-multicenter-observational-study-evaluating-four-week-changes-in-athens-insomnia-scale-among-54-participants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.97174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}